Skip to content
★ Sign in to follow
RD
Total declarations
29
Company
1
▲ Purchases (1 ops.)
€9,732
▼ Sales (4 ops.)
€2.1M

Latest filing published 08 Jul 2015 for Galectin Therapeutics INC.

Insider track record

Disclosed buys
1
Disclosed sells
4
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Rod D. Martin: trading record in brief

Rod D. Martin is a declared insider of Galectin Therapeutics Inc, with filings sourced from SEC (Form 4). In total, 29 filings cover trades dated from 13 February 2009 to 8 April 2015.

The open-market side counts 1 purchase for €9,732 alongside 4 sales for €2.1M. On balance, insiders were net sellers of €2.1M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 7 share grants and 13 option exercises.

Most recently, on 8 July 2015, the filings show a share grant in Galectin Therapeutics Inc. The last purchase on record was published on 25 May 2012, which is 5,281 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Rod D. Martin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total

10 of 10 declarations